Single Ascending Dose (BMS-813160) Study

Completed · Phase 1 · Has a placebo group

Conditions studied: Accelerated Intimal Hyperplasia

In brief

The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects

Key facts

Study ID

NCT01049165

Run by

Bristol-Myers Squibb

People needed

70

Starts

2010-02-01

Expected to finish

2010-11-01

Last updated by the study team

2011-02-11

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women (not of child bearing potential) ages 18 to 45
• Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations

You may not qualify if…

• Women of Child Bearing Potential
• Organ dysfunction or any clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations

Where it is running

• Covance Clinical Research Unit, Inc. — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.